Zsolt Kis

Dr. Zsolt Kis


Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2011 in European Journal of Pharmacology
Verified
Journal Article
Closed access
LGLevente Gellért
Levente Gellért
JFJános Fuzik
János Fuzik
AGAnikó Göblös
Anikó Göblös
KSKitti Sárközi
Kitti Sárközi
MMMáté Marosi
Máté Marosi
JTJózsef Toldi
József Toldi

1 November 2008 in Neurobiology of Disease
Verified
Journal Article
Closed access
KSKatalin Sas
Katalin Sas
HRHermina Robotka
Hermina Robotka
ÉRÉva Rózsa
Éva Rózsa
MÁMárta Ágoston
Márta Ágoston
GSGábor Szénási
Gábor Szénási
JTJozsef Toldi
Jozsef Toldi

1 November 2004 in Neuropharmacology
Verified
Journal Article
Closed access
HNH. Németh
H. Németh
HRH. Robotka
H. Robotka
ZKZsolt Kis
Zsolt Kis
ÉRÉ. Rózsa
É. Rózsa
TJTamás Janáky
Tamás Janáky
László VécseiLászló Vécsei
László Vécsei

1 August 2002 in European Journal of Neuroscience
Verified
Journal Article
Closed access
PDF file
APA. Parducz
A. Parducz
ZHZ. Hoyk
Z. Hoyk
ZKZsolt Kis
Zsolt Kis
LGLuis Miguel Garcia-Segura
Luis Miguel Garcia-Segura

16 June 2015 in Frontiers in Behavioral Neuroscience
Verified
Journal Article
Open access
PDF file
DVDániel Varga
Dániel Varga
JHJudit Herédi
Judit Herédi
ZKZita Kánvási
Zita Kánvási
MRMarian Ruszka
Marian Ruszka
ZKZsolt Kis
Zsolt Kis
LGLevente Gellért
Levente Gellért
L-Kynurenine (L-KYN) is a central metabolite of tryptophan degradation through the kynurenine pathway (KP). The systemic administration of L-KYN sulfate (L-KYNs) leads to a rapid elevation of the neuroactive KP metabolite kynurenic acid (KYNA). An elevated level of KYNA may have multiple effects on the synaptic transmission, resulting in complex behavioral changes, such as hypoactivity or spatial working memory deficits. These results emerged from studies that focused on rats, after low-dose L-KYNs treatment. However, in several studies neuroprotection was achieved through the administration of high-dose L-KYNs.In the present study, our aim was to investigate whether the systemic administration of a high dose of L-KYNs (300 mg/bwkg; i. p.) would produce alterations in behavioral tasks (open field or object recognition) in C57Bl/6j mice. To evaluate the changes in neuronal activity after L-KYNs treatment, in a separate group of animals we estimated c-Fos expression levels in the corresponding subcortical brain areas. The L-KYNs treatment did not affect the general ambulatory activity of C57Bl/6j mice, whereas it altered their moving patterns, elevating the movement velocity and resting time. Additionally, it seemed to increase anxiety-like behavior, as peripheral zone preference of the open field arena emerged and the rearing activity was attenuated. The treatment also completely abolished the formation of object recognition memory and resulted in decreases in the number of c-Fos-immunopositive-cells in the dorsal part of the striatum and in the CA1 pyramidal cell layer of the hippocampus.We conclude that a single exposure to L-KYNs leads to behavioral disturbances, which might be related to the altered basal c-Fos protein expression in C57Bl/6j mice.

2 December 2009 in Journal of Neural Transmission
Verified
Journal Article
Closed access
PDF file
MMMáté Marosi
Máté Marosi
DNDávid Nagy
Dávid Nagy
TFTamás Farkas
Tamás Farkas
ZKZsolt Kis
Zsolt Kis
ÉRÉva Rózsa
Éva Rózsa
JTJozsef Toldi
Jozsef Toldi